bloodwork
Home
Biomarkers
Categories
Panels
Conditions
Reference
LOINC parts
72,372 parts · page 617 of 1,448 ·
all codes
Part
Name
Type
Tests
LP266734-5
Episode
COMPONENT
1
LP266735-2
Trend
COMPONENT
1
LP266737-8
Exudate
COMPONENT
1
LP266738-6
Area of wound bed
COMPONENT
LP266739-4
Area of identified wound bed color
COMPONENT
LP266741-0
Wound bed panel
COMPONENT
1
LP266742-8
Wound edge panel
COMPONENT
1
LP266743-6
Wound tunneling panel
COMPONENT
1
LP266744-4
Wound undermining panel
COMPONENT
1
LP266745-1
Drug regimen review identified potential medication issues in the last 3 days
COMPONENT
1
LP266747-7
Medication follow-up in the last 3 days
COMPONENT
1
LP266748-5
Acute kidney injury risk
COMPONENT
1
LP266749-3
IRF-PAI v2.0 - Medications - admission
COMPONENT
1
LP266750-1
Bacterial 23S rRNA gene azithromycin resistance mutation
COMPONENT
1
LP266751-9
Area of wound
COMPONENT
1
LP266752-7
Tender joint
COMPONENT
2
LP266753-5
Swollen joint
COMPONENT
2
LP266756-8
Rheumatoid arthritis disease activity level
COMPONENT
1
LP266759-2
Buprenorphine-3-glucuronide
COMPONENT
2
LP266760-0
Norbuprenorphine-3-glucuronide
COMPONENT
2
LP266761-8
Insulin intact
COMPONENT
1
LP266763-4
Varicella zoster virus Ab.IgM+total
COMPONENT
1
LP266765-9
SURVEY.BDI
CLASS
LP266766-7
PANEL.SURVEY.BDI
CLASS
LP266767-5
Beck Depression Inventory II
COMPONENT
1
LP266769-1
Beck Depression Inventory Fast Screen
COMPONENT
1
LP266770-9
Patient Health Questionnaire - 9 Modified for Teens
METHOD
2
LP266771-7
Center for Epidemiologic Studies Depression Scale-Revised
METHOD
2
LP266772-5
Center for Epidemiologic Studies Depression Scale-Revised
COMPONENT
1
LP266773-3
SURVEY.CESD
CLASS
LP266774-1
PANEL.SURVEY.CESD
CLASS
LP266775-8
Patient Health Questionnaire-9: Modified for Teens
COMPONENT
1
LP266776-6
FDA-initiated compliance action drug registration and listing inactivation
COMPONENT
1
LP266778-2
Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness
METHOD
13
LP266786-5
Severe bleeding related to aspirin use
COMPONENT
1
LP266787-3
Willing to change aspirin dose
COMPONENT
1
LP266789-9
Satisfaction with using ADAPTABLE web site
COMPONENT
1
LP266790-7
Adequacy of information on+time spent reading ADAPTABLE web site
COMPONENT
1
LP266791-5
Permission to receive text messages
COMPONENT
1
LP266792-3
Insurance group number
COMPONENT
1
LP266797-2
Enteric coated aspirin tablet
COMPONENT
1
LP266799-8
Blood thinning medication use
COMPONENT
LP266800-4
Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week
COMPONENT
1
LP266801-2
Type of medication used for stomach upset
COMPONENT
1
LP266803-8
Year aspirin regimen began
COMPONENT
1
LP266805-3
Reason for discontinuing aspirin use
COMPONENT
1
LP266806-1
Line blot
METHOD
225
LP266807-9
BRAF gene V600 mutations
COMPONENT
2
LP266808-7
MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set
COMPONENT
1
LP266809-5
MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set
COMPONENT
1
← prev
·
next →